Goldman Oved, commonly abbreviated in the trade as GOI, is a proprietary fracture-filling treatment applied to diamonds containing surface-reaching fractures, most typically feathers and cleavages that would otherwise be conspicuous to the naked eye. Like the better-known Yehuda process — with which it competes directly — the Goldman Oved method works by injecting a molten glass of carefully matched refractive index into open fractures, reducing the contrast between the fracture plane and the surrounding diamond crystal and thereby improving the stone's apparent clarity grade. The treatment is classified as a clarity enhancement and, under the disclosure standards of virtually every major gemmological laboratory and trade body, must be declared at every point of sale.

Mechanism and Optical Principle

A diamond's refractive index is approximately 2.42, one of the highest of any natural gemstone. An untreated surface-reaching fracture creates a sharp optical discontinuity: light striking the fracture plane is strongly reflected rather than transmitted, making the fracture highly visible as a white or silvery flash. Fracture-filling treatments exploit the fact that a glass formulated to approach diamond's refractive index — typically in the range of 1.70 to 2.00, depending on the proprietary formula — reduces this discontinuity dramatically. The fracture does not disappear entirely, but its visibility is suppressed to a degree that can shift the apparent clarity of a stone by one or even two grades on the GIA scale.

In the Goldman Oved process, the diamond is placed in a vacuum chamber with the filling compound, which is then drawn into the fracture under controlled heat and pressure. The glass solidifies within the fracture network, bonding mechanically rather than chemically to the diamond walls. The resulting fill is optically effective but physically fragile relative to the host stone.

Identifying Characteristics

Gemmologists examining a Goldman Oved-treated diamond under darkfield illumination and fibre-optic lighting will typically observe a characteristic flash effect — a sudden shift in the colour of the fracture from orange or yellow to blue or purple (or vice versa) as the angle of observation changes. This phenomenon arises from thin-film interference within the glass fill and is the single most reliable indicator of fracture filling in diamonds. The specific colour of the flash can vary between filling compounds, and some experienced gemmologists have noted that GOI-treated stones may display a slightly different flash signature than Yehuda-treated stones, though both exhibit the phenomenon clearly.

Additional indicators include:

• Flow structures or gas bubbles trapped within the fill, visible under high magnification
• A slightly different lustre or surface texture at the fracture's intersection with a facet
• Residue or crazing at the fracture mouth, particularly in older or damaged treatments

Experienced gemmologists can identify fracture filling with confidence using a standard gemological microscope; no advanced spectroscopic equipment is required for detection, though infrared spectroscopy and energy-dispersive X-ray fluorescence (EDXF) can characterise the fill chemistry in greater detail.

Durability and Vulnerability

The glass fill used in the Goldman Oved process, like all fracture-filling compounds currently known, is significantly less stable than the diamond host. The treatment is vulnerable to several common jewellery-care procedures:

• Heat: Jeweller's torch work — including sizing, prong retipping, and soldering — can melt, boil, or discolour the fill. Even moderate heat from steam cleaners has been documented to cause damage.
• Ultrasonic cleaning: The cavitation energy generated in ultrasonic baths can dislodge or fracture the fill, sometimes causing the original fracture to become more visible than before treatment.
• Re-polishing: Any re-cutting or re-polishing of the stone will expose raw fracture surfaces and destroy the treatment entirely.
• Chemical exposure: Prolonged contact with certain acids or alkaline cleaning solutions can etch or dissolve the fill material.

For these reasons, fracture-filled diamonds require specific care instructions and should always be identified to any jeweller or bench worker before repair work is undertaken. Failure to disclose the treatment before torch work has resulted in irreversible damage to stones in numerous documented trade incidents.

Laboratory Grading and Disclosure

The GIA does not issue grading reports for fracture-filled diamonds. This policy reflects the laboratory's position that the treatment materially alters the apparent characteristics of the stone and that a clarity grade assigned to a treated stone would be misleading to subsequent owners who might not be aware of the enhancement. The AGS (American Gem Society) maintains a similar position. Some smaller or regional laboratories will issue reports for clarity-enhanced diamonds, but these reports must explicitly state the presence of fracture filling; any report that fails to do so is considered non-compliant with CIBJO and FTC disclosure guidelines.

In the United States, the Federal Trade Commission's Guides for the Jewelry, Precious Metals, and Pewter Industries require that fracture filling be disclosed at every level of the supply chain, from cutter to wholesaler to retailer to consumer. The AGTA and Jewelers of America echo these requirements in their own codes of ethics. Similar obligations apply under consumer protection law in the United Kingdom, the European Union, and most other major markets.

Market Position and Pricing

Fracture-filled diamonds, including those treated by the Goldman Oved process, trade at substantial discounts to untreated stones of comparable apparent quality. The discount reflects both the impermanence of the treatment and the disclosure obligation, which limits the pool of buyers willing to accept a treated stone. A diamond that appears to be a VS2 after GOI treatment but was a genuine SI2 or I1 before treatment will typically sell for considerably less than a natural VS2 — often at a price closer to its pre-treatment clarity, adjusted for the cosmetic improvement.

The Goldman Oved brand competes in a market segment that also includes the Yehuda process (the original and still the most widely recognised fracture-filling brand), Koss & Schechter, and several unbranded or generic filling operations. Branded treatments such as GOI and Yehuda were historically marketed with guarantees of re-treatment should the fill be damaged, though the practical enforceability of such guarantees across international supply chains has been questioned by trade observers.

Fracture-filled diamonds occupy a legitimate, if carefully circumscribed, niche in the diamond market: they allow consumers of modest means to acquire larger or more visually appealing diamonds than their budgets would otherwise permit, provided disclosure is complete and the buyer understands the nature and limitations of the enhancement. The ethical problems arise exclusively when disclosure is absent or inadequate.

Relationship to Other Fracture-Filling Treatments

The Goldman Oved process is one of several proprietary methods that emerged following the commercialisation of diamond fracture filling by Zvi Yehuda in the 1980s. The underlying chemistry and physics are broadly similar across competing brands, though each company has historically guarded the precise composition of its fill as a trade secret. Comparative studies published in Gems & Gemology have examined the flash-effect signatures and chemical profiles of fills from multiple sources, finding family resemblances but also measurable differences in refractive index, lead content, and thermal behaviour. The Goldman Oved fill has been characterised in the gemmological literature as a lead-containing glass, consistent with the high-refractive-index requirements of the application.

Further Reading

• GIA Gems & Gemology — Fracture Filling of Diamonds (foundational study)
• GIA — Diamond Treatments FAQ
• AGTA — Gemstone Treatment Information